ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0069

Activation of Cardiovascular Inflammation and Wnt Signaling in Spondyloarthritis: Insights from the HLA-B27 Transgenic Rat Model

Su-Ah Yoon, Chorong Kim, Hansun Song, Mie Jin Lim and Seong-Ryul Kwon, College of Medicine, Inha University, Incheon, Republic of Korea

Meeting: ACR Convergence 2024

Keywords: Cardiovascular, Inflammation, Metalloproteinase, spondyloarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 16, 2024

Title: SpA Including PsA – Basic Science Poster

Session Type: Poster Session A

Session Time: 10:30AM-12:30PM

Background/Purpose: Despite the well-documented link between cardiovascular (CV) disease and spondyloarthritis (SpA), no animal studies have empirically validated this connection or integrated SpA, vascular inflammation, and Wnt signaling into a single study. This study examines these associations using the HLA-B27 transgenic (TG) rat model, which closely mirrors human SpA.

Methods: Six-week-old HLA-B27 TG rats were injected with M. tuberculosis in incomplete Freund’s adjuvant, while control Lewis rats received phosphate-buffered saline. At seven weeks, HLA-B27 TG rats were classified into two groups: F1 G0 (no arthritis) and F1 G6 (severe arthritis). Both groups, along with control rats (Ctrl G0 and Ctrl G6), were analyzed for aortic protein levels. Histological examination of tail spine samples graded inflammation, bone destruction, and osteoproliferation.

Results: All F1 G6 rats developed clinical arthritis, with 60% also exhibiting spondylitis. Histological analysis revealed a correlation between inflammation and osteoproliferation in F1 G6 rats (r2 = 0.7992, p = 0.041). Aortic protein levels were significantly higher in F1 G6 rats compared to Ctrl G6 rats, with increased expressions of WNT3, LRP5, WNT5, Runt-related transcription factor 2, TNFα, and IL-17 (all p = 0.009, except TNFα at p = 0.028). Elevated levels of WNT3, LRP5, WNT5, matrix metalloproteinase 3, TNFα, IL-17, and IL-23 were also observed in F1 G6 compared to F1 G0 rats (all p < 0.05). (Fig. 1)

Conclusion: These findings suggest that arthritis and spondylitis in SpA may contribute to the development of CV disease by activating Wnt signaling, MMP3, and inflammatory pathways in the CV system.

Supporting image 1

Figure 1. Density histogram data based on the results of western blot analyses of aorta, which represent the relative expression of Wnt signaling, inflammatory markers, and MMP3. F1 G0: 7-wk-old arthritis-free F1 rats, F1 G6: clinical arthritis of grade 6 or higher F1 rats, Ctrl G0: 7-wk-old control Lewis rats, Ctrl G6: Control Lewis rats with age- and sex-matched F1 rats.


Disclosures: S. Yoon: None; C. Kim: None; H. Song: None; M. Lim: None; S. Kwon: None.

To cite this abstract in AMA style:

Yoon S, Kim C, Song H, Lim M, Kwon S. Activation of Cardiovascular Inflammation and Wnt Signaling in Spondyloarthritis: Insights from the HLA-B27 Transgenic Rat Model [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/activation-of-cardiovascular-inflammation-and-wnt-signaling-in-spondyloarthritis-insights-from-the-hla-b27-transgenic-rat-model/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/activation-of-cardiovascular-inflammation-and-wnt-signaling-in-spondyloarthritis-insights-from-the-hla-b27-transgenic-rat-model/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology